Since the liver produces about 90% of AAT in our body, intrahepatic Z-AAT retention can cause liver damage with variable clinical presentations ranging from neonatal cholestasis to liver cirrhosis and hepatocellular carcinoma in adults [8]. The gene discussed is SERPINA1; the disease is cirrhosis of liver.